I think the Australian share market has a number of high quality small cap technology shares that could grow materially in the future and generate strong returns for shareholders.
Three that have caught my eye in 2019 are listed below. Here’s why I think they are worth considering:
Audinate Group Limited (ASX: AD8)
Audinate is a fast-growing provider of audio-visual networking technologies to the professional live sound, commercial installation, broadcast, and recording industries. The key product in its arsenal is the award-winning Dante audio over IP networking solution. This product has been growing in popularity and driving strong sales growth. And given its sizeable market opportunity and new product launches, I believe it is well-placed to continue this strong growth for some time to come.
Straker Translations (ASX: STG)
Another small cap tech share that I think has outstanding long term growth potential is Straker Translations. It is a translation services platform provider which uses a combination of artificial intelligence and human intelligence to provide efficient language translation services at scale in a market tipped to be worth upwards of US$66 billion by 2022. Given the quality of its services, I expect Straker to continue to win a greater slice of this market over the next decade.
Volpara Health Technologies Ltd (ASX: VHT)
This healthcare technology company is another at the small side of the market which I think could be destined for big things. Volpara Health Technologies provides software which uses artificial intelligence imaging algorithms to assist with the early detection of breast cancer. It has been growing its market share in the United States at a rapid rate, leading to strong annual recurring revenue growth. And thanks to recent acquisitions and a growing footprint, Volpara appears to be well-positioned to continue its meteoric growth in FY 2020 and beyond.
And here is another small cap share which could potentially outperform the rest of them. It was recently rated as a buy.
A little-known ASX company just unlocked what some experts think could be the key to profiting off the coming marijuana boom.
And make no mistake – it is coming. To the tune of an estimated $US22 billion.
Cannabis legalisation is sweeping over North America, and full legalisation arrived in Canada in October 2018.
Here's the best part: we think there's one ASX stock that's uniquely positioned to profit immensely from this explosive new industry... taking savvy investors along for what could be one heck of a ride.
AND, this is the first time The Motley Fool Australia has EVER put a BUY recommendation on a marijuana stock.
Simply click below to learn more on how you can profit from the coming cannabis boom.
- NEW: Free report names top 3 ASX dividend shares to buy for 2019
- Top analysts name their top 3 ASX blue chip shares for 2019
- Richest man alive issues dire warning
- 3 quality dividend shares to boost your income
James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of VOLPARA FPO NZ. The Motley Fool Australia owns shares of and has recommended AUDINATEGL FPO. The Motley Fool Australia has recommended Straker Translations and VOLPARA FPO NZ. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.
The Motley Fool's purpose is to help the world invest, better. Click here now for your free subscription to Take Stock, The Motley Fool's free investing newsletter. Packed with stock ideas and investing advice, it is essential reading for anyone looking to build and grow their wealth in the years ahead. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson. 2019